Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

HHS has notified Moderna that it is canceling a nearly $600 million contract for vaccines for flu strains that could trigger ...

With the continued use of COVID-19 vaccines worldwide, there’s a massive amount of data that shows mRNA shots are safe.

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.